Market Overview

UPDATE: Credit Suisse Raises PT to $41 on HCA Holdings on Positive Reform Exposure

Share:
Related HCA
Senate Unveils Its Version of Trumpcare: Healthcare Stocks Up
Should Value Investors Pick HCA Healthcare (HCA) Stock Now?
TrumpCare Is Back On Life Support: Nevada Senator Heller Slams Bill (Investor's Business Daily)

Credit Suisse maintained HCA Holdings (NYSE: HCA) with a Market Perform rating and raised the price target from $30.00 to $39.00.

Credit Suisse noted, "HCA reported 4Q12 EPS of $0.91, well ahead of consensus of $0.82 and ahead of our $0.89 estimate, driven by strong organic volume growth. The company also issued 2013 guidance that fell below consensus, which was not overly surprising. However, shares traded off early highs as mgmt provided somewhat reserved commentary around healthcare reform, pointing to many uncertainties that still exist, and the likelihood of a multi-yr ramp. We continue to believe reform will be a meaningful positive in 2014 and the 4Q results reinforce the strong market position and execution by HCA."

HCA Holdings closed at $37.51 on Tuesday.

Latest Ratings for HCA

DateFirmActionFromTo
Jun 2017Morgan StanleyInitiates Coverage OnEqual-Weight
Jun 2017Leerink SwannUpgradesMarket PerformOutperform
Apr 2017Deutsche BankInitiates Coverage OnBuy

View More Analyst Ratings for HCA
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color Price Target Analyst Ratings

 

Related Articles (HCA)

View Comments and Join the Discussion!